News
Individuals who received either the AS01 shingles or RSV vaccine had a significantly lower risk of developing dementia.
Compared with flu vaccine recipients, those given the RSV or shingles vaccine had 18% to 37% lower odds of receiving a ...
New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...
Researchers found that older adults who received AS01-adjuvanted shingles or RSV vaccines had a significantly lower risk of ...
Recent studies have shown convincingly that vaccines against shingles (Herpes zoster) reduce the risk of dementia.
Two AS01-adjuvanted vaccines for different pathogens -- the respiratory syncytial virus (RSV) vaccine (Arexvy) and the ...
A new study by the University of Oxford, published in the journal npj Vaccines, shows that a vaccine against respiratory syncytial virus (RSV) is associated with a 29% reduction in dementia risk in ...
A new study shows that a vaccine against respiratory syncytial virus is associated with a 29% reduction in dementia risk in the following 18 months. The findings suggest a novel explanation for how ...
A new study shows that a vaccine against respiratory syncytial virus is associated with a 29% reduction in dementia risk in the following 18 months. The findings suggest a novel explanation for how ...
A study published in NPJ Vaccines looks at adjuvants in vaccines and their association with a lower risk of dementia. Dr Julia Dudley, Head of Research at Alzheimer’s Research UK, said: ...
Some vaccines may reduce the risk of dementia through a double effect in which the jabs help protect the brain through their added “adjuvant” chemicals as well as by suppressing viruses, according to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results